A lot happened in the world of pharmaceuticals this year. The opioid crisis worsened. The FDA got a new chief. There were big failures and prices reemerged as a major issue. Industry needed to contend with the new Trump administration and gene therapy ‘came of age.’
By the way, here is one year in review article that showcases some of these ideas:
The following article is a short version of BP Round-up. Why? Happy New Year and Hogmanay!
Let’s start with cannabis:
Money-making? Here are some tips and stories:
Also, I’ll be speaking in Glasgow about Big Pharma and other topics on January 22nd.